As the drug safety landscape shifts, so do the methods for AE reporting. Traditional sources of adverse event reporting include clinical trial investigator site and post marketing medical information call center. However, potential adverse event reporting can occur in any patient interaction program, such as specialty pharmacies, patient assistance programs, and patient adherence services. Because capturing drug safety information is paramount, I chose this topic for my presentation at last week’s HNC U.S.
With 40+conferences spanning all service lines and more than 20 UBC experts slated to present in cities across North America and Europe, we have a lot to look forward to in 2014. In order to help you set your calendar for the first quarter, here are a few events where we will be exhibiting. We hope to see you!
Traditionally, chart review studies have been employed to evaluate burden of illness and patterns of care, but, increasingly, this methodology is being applied to meet marketing authorization and risk management data requirements including data that reflect patterns of off label medication use.